ReviewInflammation2026
Mitochondria as Inducers of Neutrophil Extracellular Traps.
Review in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Calcium-dependent redox signaling connects mitochondrial remodeling with PAD-associated NETosis during respiratory mycoplasma infection.Redox biology · 2026Article
- Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting.Biomarker research · 2026Review
- Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions.Biomolecules · 2026Review
- Reframing ME/CFS: toward a unified mechanistic model of chronic post-infectious diseases.Journal of translational medicine · 2026Review
- Pathological triad of perioperative acute kidney injury: renal microcirculatory hypoxia, mitochondrial damage, and immuno-metabolic reprogramming.Frontiers in immunology · 2026Review
- Inflammatory responses driven by neutrophil extracellular traps in cardiovascular diseases: molecular mechanisms, emerging biomarkers, and therapeutic targets.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neutrophil extracellular traps (NETs) represent a critical immune defense mechanism that can become pathological in sterile inflammation. Mitochondrial damage-associated molecular patterns (mtDAMPs) emerge as particularly potent triggers of NET formation due to their bacterial-like molecular features inherited from endosymbiotic origins. This review examines the mechanisms by which key mtDAMPs, including mitochondrial DNA, ATP, cardiolipin, cytochrome c, succinate, heme and formylated peptides, induce NETosis through pattern recognition receptors typically reserved for pathogen detection. We describe the complex signaling networks downstream of mtDAMP recognition, highlighting the roles of membrane and intracellular receptors and mitogen-activated protein kinase pathways in orchestrating mtDAMP-induced NET formation. The clinical relevance of mtDAMP-induced NETosis is explored across trauma and wound healing contexts, where neutrophil phenotype along with concentration-dependent and temporal dynamics determine beneficial versus pathological outcomes. Current therapeutic approaches modulating NET formation are discussed challenges in stimulus specificity, pathway redundancy, and use of analgesics and anti-inflammatory drugs. We conclude with future research priorities that include establishing clinically relevant concentration thresholds, elucidating synergistic mtDAMP effects, and developing targeted therapeutic strategies for NET-mediated pathology in sterile inflammatory conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.